Duke University Medical Center
Durham, North Carolina, 27710, United States
NCT Number: NCT04679402
This project will test the following hypotheses:
1. Training of the inspiratory muscles increases underwater endurance and reduces hypercapnia in divers. 2. Inspiratory muscle training while breathing low concentration carbon monoxide (200 ppm) for 30 minutes daily improves diaphragm performance to a greater degree than the same training breathing air. 3. Inspiratory muscle training increases hypercapnia ventilatory response (gain) in those individuals with a low gain. 4. Variability in oxygen (O2) and carbon dioxide (CO2) permeability of erythrocyte membranes is a determining factor in underwater exercise performance.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
The aims of this project are to: (1) test a method that could increase personal endurance and reduce excessive rise in blood carbon dioxide during underwater exercise in divers; and (2) understand the mechanisms by which red blood cells transport oxygen and carbon dioxide and their possible effects on exercise capacity. During underwater exercise, personal endurance capacity and elevated blood PCO2 are key parameters that affect a diver's safety and performance. Unlike exercise on dry land, hypercapnia often occurs during dives and can impair cognitive function and predispose the diver to central nervous system (CNS) oxygen toxicity and convulsions underwater. Some people intrinsically have low ventilatory chemosensitivity, and are more likely to develop hypercapnia during a dive. Lack of stamina may also be a mission-critical variable, and both endurance and the ability to control blood carbon dioxide depend on the respiratory muscle (mainly diaphragm) function, for which endurance capacity is related to mitochondrial number. Previous studies from our lab have demonstrated increased mitochondrial biogenesis with training while breathing a low, sub-toxic (200 ppm) level of carbon monoxide. In this study we will test the effect of daily respiratory muscle training with and without added carbon monoxide on respiratory muscle power, diaphragm thickness, respiratory muscle endurance and exercise endurance during a subsequent dive to 50 feet of sea water. Arterial PCO2 and lactic acid levels will be measured during exercise tests before and after training. Transport of O2 and CO2 through erythrocyte cell membranes occurs mostly through channels. Erythrocytes from volunteers in this study will be tested for O2 and CO2 permeability, and to correlate gas transport efficiency with exercise performance and blood PCO2.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Low dose carbon monoxide
Time frame: Baseline, 6 weeks
Endurance during continuous underwater exercise at a depth of 50 ft below the surface
Time frame: Baseline, 6 weeks
Blood gases during and at end of exercise
Time frame: Baseline, 6 weeks
Hypercapnic ventilatory response (VE.min-1.mmHg)
Time frame: Baseline
Stopped-flow analysis of O2 offloading from Hb of (a) intact RBCs, (b) Hb in hemolysate
Duke University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07144878
Intensive Care Units, Pathologic Processes
Banhā, Egypt
View Trial DetailsNCT06454539
Behavior, Brain Diseases
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT05380687
Critical Care, Pathologic Processes
Edegem, Antwerp, Belgium
View Trial DetailsNCT05669196
Lung Diseases, Lung Neoplasms
Ankara, Turkey (Türkiye)
View Trial Details